These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20670842)

  • 21. [The importance of determination of Nt-proBNP and big endothelin in diagnosing chronic heart failure in patients on regular haemodialysis treatment].
    Ludka O; Spinar J; Vítovcová L; Sobotová D; Spinarová L; Vítovec J; Tomandl J
    Vnitr Lek; 2007 Jan; 53(1):38-45. PubMed ID: 17472014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum albumin and mortality in acutely decompensated heart failure.
    Uthamalingam S; Kandala J; Daley M; Patvardhan E; Capodilupo R; Moore SA; Januzzi JL
    Am Heart J; 2010 Dec; 160(6):1149-55. PubMed ID: 21146671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
    Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
    Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive mediators in patients with acute liver failure treated with albumin dialysis.
    Kortgen A; Hetz H; Morgenthaler NG; Paxian G; Hitzler P; Krenn CG; Bauer M
    Liver Int; 2010 Apr; 30(4):634-6. PubMed ID: 19780957
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
    Dini FL; Buralli S; Bajraktari G; Elezi S; Duranti E; Metelli MR; Carpi A; Taddei S
    Biomed Pharmacother; 2010 May; 64(5):339-42. PubMed ID: 19944559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
    Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards AM
    J Am Coll Cardiol; 2007 Jan; 49(4):461-71. PubMed ID: 17258092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of high sensitivity CRP in patients with diastolic heart failure.
    Michowitz Y; Arbel Y; Wexler D; Sheps D; Rogowski O; Shapira I; Berliner S; Keren G; George J; Roth A
    Int J Cardiol; 2008 Apr; 125(3):347-51. PubMed ID: 17467828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Severe" congestive heart failure at a medical center].
    Ferreira P; Fonseca C; Morais H; Carvalho A; Ceia F; Luís AS
    Rev Port Cardiol; 1993 Nov; 12(11):919-30, 900. PubMed ID: 8305244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
    Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
    Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
    Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urocortin: molecular biology and cardiovascular effects].
    Raddino R; Pedrinazzi C; Zanini G; Robba D; Bonadei I; Scarabelli TM; Cas LD
    G Ital Cardiol (Rome); 2007 Apr; 8(4):236-45. PubMed ID: 17506295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of periodic leg movements during sleep and mortality in patients with systolic heart failure.
    Yumino D; Wang H; Floras JS; Newton GE; Mak S; Ruttanaumpawan P; Parker JD; Bradley TD
    Am J Cardiol; 2011 Feb; 107(3):447-51. PubMed ID: 21257013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse remodelling in systolic heart failure: A puzzle yet to be solved?
    Yalta K
    Int J Cardiol; 2015 May; 187():46-7. PubMed ID: 25828311
    [No Abstract]   [Full Text] [Related]  

  • 40. Answer. Reverse remodeling in systolic heart failure. The ST2-R2 score: a puzzle yet to be solved?
    Lupón J; Bayes-Genis A
    Int J Cardiol; 2015 May; 187():556. PubMed ID: 25880401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.